CLNN - Clene Inc. logo

Clene Inc.

CLNN

Clene Inc. develops novel clean-surfaced nanotechnology therapeutics, focusing on treating neurodegenerative diseases like ALS and Parkinson's. It also produces antimicrobial gels and dietary supplements containing zinc and gold for health support and wound healing.

โš’๏ธ Consumer Defensive NASDAQ Listed 2020 $ USD
$1,000 invested 5 years ago โ†’$34today

Score Overview

1 Year
Score
Net Growth-50.99%
Net TrendShrank
Net Income Consistencyโ€”
Rev Growth-1.50%
Rev TrendShrank
Revenue Consistencyโ€”
5 Years
Score2.3
Net Growth-305.73%
Net Trend40%
Net Income Consistencyโ€”
Rev Growth-72.75%
Rev Trend20%
Revenue Consistencyโ€”
All Time
Score
Net Growth-105.00%
Net Trend50%
Net Income Consistency
Rev Growth-4.37%
Rev Trend33%
Revenue Consistency

Explore the 2021 public Archive ranking โ†’

Where Clene Inc. has ranked, year by year

Measure
Fundamentals Window

Not enough ranking history to display a chart

This chart needs at least two years of available HDB Score rankings on 10 years of fundamentals. CLNN does not have enough ranked years in the public Archive through 2021.

More recent Archive years are available with Membership. Coverage varies by company and measure.

Net Income x Stock Price

Historical Returns

Historical Returns
PeriodPriceReturn
Last Price2026-10-22
$ 3.88โ€”
1 Year2025-10-22
$ 7.97-51.32%
5 Years2021-10-22
$ 114.60-96.61%
All Time2020-12-31
$ 180.20-97.85%

Prices are split & dividend adjusted. All values are reported in USD.

Fundamental Data

Reported in USD

Year
TTM$ 197K-$ 39M$ 9M
2025$ 200K-$ 26M$ 5M
2024$ 342K-$ 39M$ 12M
2023$ 654K-$ 49M$ 35M
2022$ 473K-$ 29M$ 23M
2021$ 723K-$ 9M$ 50M
IPO2020$ 206K-$ 19M$ 59M
CLNN - Clene Inc. logo

Clene Inc. fundamental performance

Across Clene Inc.'s full reported history, from 2020 to 2025, revenue declined from $ 206K to $ 200K and net income went from -$ 19M to -$ 26M. Revenue increased in 33% of the years measured; net income in 50%.

Clene Inc. currently holds a 5-year HDB Score of 2.3 out of 10. How the HDB Score is calculated.

Membership

Explore CLNN with current data

The public Archive runs through 2021. Membership adds recent and current rankings.

  • Recent and current rankings across 5,119 companies
  • Compare companies with the latest data
  • Track your research shortlist in a portfolio

$99 / year

$149/year ยท Founding price

Continue with Membership

30-day money-back guarantee.

Explore other companies